Swedish, Dutch Firms' Clinical Data Alliance

5 December 1994

Minidoc of Sweden and the Dutch 1st Line Medical group have signed an agreement to merge their systems for collecting data from patients and doctors in drug trials.

The Minidoc product is an electronic patient diary programmed with questions on the medication. An in-built alarm signal indicates that it is time to answer questions on drug effects which, says Minidoc, increases the reliability of the trials. The Dutch Quest product is a similar paperless system, but is adapted for comments from doctors and project leaders. The firms say that together, their systems cover "a whole chain of people involved in a drug trial," and that the agreement "could save manufacturers $5 million a week."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight